Nuveen’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.06M | Sell |
186,758
-9,961
| -5% | -$193K | ﹤0.01% | 1969 |
|
|
2025
Q4 | $4.23M | Buy |
196,719
+25,079
| +15% | +$529K | ﹤0.01% | 1984 |
|
|
2025
Q3 | $3.31M | Sell |
171,640
-2,644
| -2% | -$47.1K | ﹤0.01% | 2101 |
|
|
2025
Q2 | $2.98M | Sell |
174,284
-178,456
| -51% | -$7.61M | ﹤0.01% | 2120 |
|
|
2025
Q1 | $22.5M | Sell |
352,740
-171,839
| -33% | -$18.1M | 0.01% | 1062 |
|
|
2024
Q4 | $63.8M | Buy |
524,579
+50,379
| +11% | +$6.17M | 0.02% | 546 |
|
|
2024
Q3 | $59.2M | Sell |
474,200
-9,035
| -2% | -$1.25M | 0.02% | 574 |
|
|
2024
Q2 | $76.4M | Sell |
483,235
-59,340
| -11% | -$7.62M | 0.02% | 483 |
|
|
2024
Q1 | $70.2M | Buy |
542,575
+9,318
| +2% | +$1.14M | 0.02% | 525 |
|
|
2023
Q4 | $51.4M | Sell |
533,257
-28,325
| -5% | -$2.72M | 0.02% | 593 |
|
|
2023
Q3 | $68.1M | Sell |
561,582
-26,429
| -4% | -$2.99M | 0.02% | 474 |
|
|
2023
Q2 | $67.3M | Buy |
588,011
+56,982
| +11% | +$7.35M | 0.02% | 482 |
|
|
2023
Q1 | $73.2M | Buy |
531,029
+181,380
| +52% | +$23.5M | 0.03% | 440 |
|
|
2022
Q4 | $45.3M | Buy |
349,649
+22,780
| +7% | +$2.64M | 0.02% | 575 |
|
|
2022
Q3 | $36.1M | Buy |
326,869
+7,326
| +2% | +$738K | 0.01% | 671 |
|
|
2022
Q2 | $24M | Buy |
319,543
+7,251
| +2% | +$533K | 0.01% | 927 |
|
|
2022
Q1 | $25.3M | Sell |
312,292
-44,142
| -12% | -$3.38M | 0.01% | 1037 |
|
|
2021
Q4 | $32.1M | Sell |
356,434
-60,400
| -14% | -$5.16M | 0.01% | 945 |
|
|
2021
Q3 | $38.5M | Sell |
416,834
-36,500
| -8% | -$2.81M | 0.01% | 835 |
|
|
2021
Q2 | $35.2M | Buy |
453,334
+72,341
| +19% | +$5.48M | 0.01% | 951 |
|
|
2021
Q1 | $28.4M | Sell |
380,993
-116,634
| -23% | -$10.8M | 0.01% | 1062 |
|
|
2020
Q4 | $84.8M | Buy |
497,627
+59,775
| +14% | +$8.86M | 0.03% | 480 |
|
|
2020
Q3 | $61.5M | Buy |
437,852
+20,430
| +5% | +$3.1M | 0.02% | 510 |
|
|
2020
Q2 | $66.9M | Buy |
417,422
+81,180
| +24% | +$11M | 0.03% | 479 |
|
|
2020
Q1 | $32.9M | Buy |
336,242
+45,838
| +16% | +$5.24M | 0.02% | 642 |
|
|
2019
Q4 | $37.5M | Buy |
290,404
+3,688
| +1% | +$372K | 0.01% | 825 |
|
|
2019
Q3 | $21.6M | Sell |
286,716
-23,458
| -8% | -$2.77M | 0.01% | 1084 |
|
|
2019
Q2 | $47.1M | Buy |
310,174
+283,766
| +1,075% | +$34.5M | 0.02% | 704 |
|
|
2019
Q1 | $3.15M | Buy |
+26,408
| New | +$3.4M | 0.02% | 578 |
|
|
2018
Q2 | – | Sell |
-3,866
| Closed | -$286K | – | 1113 |
|
|
2018
Q1 | $286K | Sell |
3,866
-16,597
| -81% | -$1.11M | ﹤0.01% | 984 |
|
|
2017
Q4 | $1.14M | Sell |
20,463
-10,014
| -33% | -$530K | 0.01% | 713 |
|
|
2017
Q3 | $1.38M | Sell |
30,477
-1,338
| -4% | -$53.5K | 0.01% | 689 |
|
|
2017
Q2 | $1.07M | Buy |
31,815
+3,226
| +11% | +$105K | 0.01% | 742 |
|
|
2017
Q1 | $846K | Buy |
28,589
+10,048
| +54% | +$311K | 0.01% | 1021 |
|
|
2016
Q4 | $509K | Buy |
18,541
+614
| +3% | +$24.7K | ﹤0.01% | 1314 |
|
|
2016
Q3 | $1.1M | Buy |
+17,927
| New | +$542K | 0.01% | 1048 |
|
Other funds holding SRPT
VPM
VCM
RCM
EAM
